Skip to content
PCE
Search Classifications
Search for IPC and CPC classification codes or keywords
DIFF Subgroup
A61P 25/28

for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Introduced: January 2000

Full Title

Drugs for disorders of the nervous system > for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

No child classifications to compare. This is a leaf node in both IPC and CPC.

Top Applicants

Top Applicants (IPC)

Class A61,2013–2023, worldwide · Source: EPO PATSTAT

  1. PHILIPS ELECTRONICS NL 18,523
  2. NOVARTIS CH 14,253
  3. COVIDIEN US 13,953
  4. ROCHE CH 12,005
  5. CHINESE ACADEMY OF SCIENCES 11,955
  6. UNIVERSITY OF CALIFORNIA US 11,692
  7. HARVARD UNIVERSITY US 11,596
  8. L'OREAL FR 11,593
  9. P&G (PROCTER & GAMBLE COMPANY) US 11,297
  10. OLYMPUS CORPORATION JP 9,594

Top Applicants (CPC)

Class A61,2013–2023, worldwide · Source: EPO PATSTAT

  1. PHILIPS ELECTRONICS NL 20,621
  2. NOVARTIS CH 15,792
  3. ROCHE CH 14,303
  4. COVIDIEN US 13,862
  5. HARVARD UNIVERSITY US 13,454
  6. UNIVERSITY OF CALIFORNIA US 12,798
  7. P&G (PROCTER & GAMBLE COMPANY) US 12,140
  8. L'OREAL FR 11,800
  9. OLYMPUS CORPORATION JP 9,894
  10. BOSTON SCIENTIFIC SCIMED US 9,513